Biogen’s Singhal Offers A Look Into Company's Pipeline Review
Explains How Company Validated Its Assets, Reduced Portfolio Risk
Priya Singhal, head of development, spoke with Scrip about the company’s R&D restructuring, readouts coming from the culled pipeline and how Biogen is thinking about adding to it in the future.
